Skip to content
Medonix

Denial reduction · Multi-specialty group

Cath-lab denial rate from 11.2% to 3.4% in 90 days.

A 12-provider cardiology group in Houston was bleeding revenue on cath-lab denials and modifier 25 / 59 errors. Inside one quarter on Medonix, denial rate dropped to 3.4% and the appeal-overturn queue cleared an aged backlog worth roughly $480,000.

  • Multi-specialty group · Cardiology
  • Client: 12-provider cardiology group
  • State: TX
  • Denial reduction

Outcome at a glance

Before and after, on the metrics that mattered.

Denial rate

11.2%3.4%

Aged backlog

$480KRecovered

Days in A/R

52d17d

The situation

Where the practice was when Medonix engaged.

A 12-provider cardiology group in Houston had been operating with a denial rate above 10% for the better part of two years. Cath-lab procedures (CPT 92920 series and 93000 series) were denying inconsistently across BCBS of Texas and UnitedHealthcare commercial plans, and the practice could not pin down whether the issue was coding, modifier sequencing, or payer-policy drift.

The internal billing team of three was working at capacity submitting new claims, which meant aged A/R was getting almost no attention. By the time the group brought Medonix in, the >60-day A/R bucket had grown to roughly $480,000, with another $1.1M in 30-to-60-day claims at risk.

The practice CFO had received two prior vendor proposals that quoted higher rates than the in-house cost without committing to a measurable denial-reduction outcome. They wanted the work done with skin in the game.

The work

What Medonix actually did.

Discovery and audit ran for 14 days. A senior strategist pulled six months of remits and categorized every denial by CARC code, payer, CPT family, and root cause. The output was a heat map showing that 62% of denials concentrated in three patterns: modifier 25 with E/M on a procedure day (CO-97), missing prior auth on diagnostic catheterizations (CO-197), and incorrect modifier 59 unbundling on dual-vessel interventions.

Parallel-run onboarding ran days 14 through 44. Medonix integrated to the practice EHR, built payer-specific scrub rules for the three top denial reasons, and shipped test claims behind the scenes while the internal team continued production submission. By day 30, the scrub rules were catching the same denial patterns at the clearinghouse layer with measured accuracy.

Cutover happened on day 45. From day 45 forward, every claim flowed through Medonix with the new scrub-rule engine and the AI denial-categorization workflow. AAPC-credentialed cardiology coders worked the existing aged backlog with payer-specific appeal templates pre-built per denial reason.

The outcome

Where the practice landed.

By day 90, the practice denial rate had dropped from 11.2% to 3.4% measured first-pass. The aged backlog of $480,000 had been worked with an appeal-overturn rate of 71%, recovering approximately $341,000 in cash that had been tracking toward write-off.

Days in A/R compressed from 52 to 17 over the same window, primarily by clearing the aged claims that had been dragging the average. The internal billing team transitioned from production submission to oversight of the Medonix relationship, with two of three positions kept and refocused on payer-contracting and patient financial services.

The CFO's quarterly board update for Q2 reported a $341,000 recovery, a normalized 3.4% denial rate, and an annualized run-rate revenue lift of approximately $620,000 from prevented denials going forward.

Want a reference like this one

Talk to a Medonix client in multi-specialty group.

Book a discovery call and we will arrange a reference call with a Medonix client whose specialty, payer mix, and industry profile matches yours. Twenty to thirty minutes, no Medonix on the line.

Book a discovery call

Frequently asked

About this case study.

For methodology detail under NDA, email hello@medonix.io.

A 12-provider cardiology group in Houston was bleeding revenue on cath-lab denials and modifier 25 / 59 errors. Inside one quarter on Medonix, denial rate dropped to 3.4% and the appeal-overturn queue cleared an aged backlog worth roughly $480,000.

Talk to RCM

Ready to recover every dollar your practice earns?

See your projected revenue lift in 60 seconds, or talk to a senior RCM strategist now. No commitment. Same-day slots available.

  • 30-day parallel-run guarantee
  • Targets written into the contract
  • HIPAA · SOC 2 Type II · HITRUST
Get a free audit +1-302-520-5413

24/7 · U.S. healthcare only